Showing results (1-10 of 54) with videos related to
Sort By:
Pageof 6
Research Communications in Chemical Pathology and Pharmacology|July 1, 1976
In vivo dopamine release and prostaglandin E2P F VonVoigtlanderResearch Communications in Chemical Pathology and Pharmacology|March 1, 1976
On the use of selective neurotoxic amine analogs to measure the blockade of norepinephrine and 5-hydroxytryptamine uptake systems by antidepressantsP F VonVoigtlander, E G LoseyBrain Research|June 10, 1977
Prostaglandin E2, cyclic adenosine monophosphate and morphine analgesiaP F Vonvoigtlander, E G LoseyResearch Communications in Chemical Pathology and Pharmacology|May 1, 1978
In vivo disposition and metabolism of enkephalins: relationship to analgesic propertiesP F VonVoigtlander, R A LewisJournal of Pharmacological Methods|December 1, 1983
A withdrawal hyperalgesia test for physical dependence: evaluation of mu and mixed-partial opioid agonistsP F VonVoigtlander, R A LewisJournal of Pharmacological Methods|August 1, 1991
A rapid screening method for the assessment of benzodiazepine receptor-related physical dependence in mice. Evaluation of benzodiazepine-related agonists and partial agonistsP F VonVoigtlander, R A LewisDrug Design and Delivery|December 1, 1987
Evidence for the combined involvement of serotonergic and alpha 2 adrenergic mechanisms in the analgesic activity of tazadolene succinateP F Vonvoigtlander, R A LewisThe Journal of Pharmacology and Experimental Therapeutics|July 1, 1988
Analgesic and mechanistic evaluation of spiradoline, a potent kappa opioidP F Vonvoigtlander, R A LewisLife Sciences|November 15, 1982
Properties of a selective kappa agonist, U-50,488HR A Lahti, P F VonVoigtlander, C BarsuhnJournal of Medicinal Chemistry|April 1, 1981
4-amino-4-arylcyclohexanones and their derivatives: a novel class of analgesics. 2. Modification of the carbonyl functionD Lednicer, P F VonVoigtlander, D E EmmertPageof 6